NCT00323063 2023-03-29
Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated
Clinical Trials
3 trialsNCT00080665 2018-04-24
Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00045188 2013-01-23
Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed